[go: up one dir, main page]

DE60018715D1 - Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil - Google Patents

Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil

Info

Publication number
DE60018715D1
DE60018715D1 DE60018715T DE60018715T DE60018715D1 DE 60018715 D1 DE60018715 D1 DE 60018715D1 DE 60018715 T DE60018715 T DE 60018715T DE 60018715 T DE60018715 T DE 60018715T DE 60018715 D1 DE60018715 D1 DE 60018715D1
Authority
DE
Germany
Prior art keywords
propylene glycol
cyclosprin
pharmaceutical composition
active ingredient
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60018715T
Other languages
English (en)
Other versions
DE60018715T2 (de
Inventor
Amarjit Singh
Rajesh Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Application granted granted Critical
Publication of DE60018715D1 publication Critical patent/DE60018715D1/de
Publication of DE60018715T2 publication Critical patent/DE60018715T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60018715T 2000-05-04 2000-05-04 Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil Expired - Fee Related DE60018715T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00201627A EP1151755B1 (de) 2000-05-04 2000-05-04 Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil

Publications (2)

Publication Number Publication Date
DE60018715D1 true DE60018715D1 (de) 2005-04-21
DE60018715T2 DE60018715T2 (de) 2006-04-27

Family

ID=8171456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60018715T Expired - Fee Related DE60018715T2 (de) 2000-05-04 2000-05-04 Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil

Country Status (6)

Country Link
EP (1) EP1151755B1 (de)
AT (1) ATE290876T1 (de)
DE (1) DE60018715T2 (de)
DK (1) DK1151755T3 (de)
ES (1) ES2235765T3 (de)
PT (1) PT1151755E (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP89008A (en) 2001-10-19 2011-12-20 Novel cyclosporin analog microemulsion preconcentrates
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
EP1748759B1 (de) * 2004-04-27 2013-03-27 Javeri, Indu Verfahren zur verbesserung der wasserlöslichkeit von hydrophoben verbindungen durch mizellendispersionen
RU2009116423A (ru) * 2006-10-31 2010-12-10 Вайет (Us) Композиции ингибиторов фермента фосфолипазы
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2011038073A1 (en) 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes comprising docetaxel
ITMI20111050A1 (it) * 2011-06-10 2012-12-11 Sevecom Spa Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali.
EP3177153A1 (de) 2014-07-21 2017-06-14 Sevecom S.p.A. Pulverförmige emulsion für tierfutter

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
EP0982035B1 (de) * 1998-08-18 2004-03-31 Panacea Biotec Limited Zusammensetzung enthalten Cyclsoporin in einem hydrophilen Träger

Also Published As

Publication number Publication date
EP1151755B1 (de) 2005-03-16
PT1151755E (pt) 2005-05-31
ATE290876T1 (de) 2005-04-15
DK1151755T3 (da) 2005-06-27
DE60018715T2 (de) 2006-04-27
EP1151755A1 (de) 2001-11-07
ES2235765T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
CO4761073A1 (es) Preparados que contienen ciclosporina
DE60018715D1 (de) Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil
DE69921409D1 (de) Cyclosporin enthaltende Zusammensetzungen
EE200300235A (et) Ravimpreparaat, milles aktiivne ingredient on ühtlaselt dispergeeritud abiainete alussegus, ning seda sisaldav doseerimisvorm
AP2000001943A0 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
ES2186715T3 (es) Uso de un tensioactivo lipofilico en una composicion farmaceutica.
MX9800188A (es) Composiciones topicas estables.
CA2166388A1 (en) Antifungal composition for external use retentive in stratum corneum
TW200716113A (en) Matrix for sustained, invariant and independent release of active compounds
PT786986E (pt) Formulacoes farmaceuticas
CO5140102A1 (es) Formulacion farmaceutica en forma de pasta semisolida estabilizada para administracion oral que comprende omeprazol, de dos a cuatro agentes basificantes, un agente espesante y un vehiculo aceitoso hidrofobico
WO2003032933A8 (de) Kosmetische und/oder pharmazeutische rückfettende zubereitungen
PT1124415E (pt) Agentes repelente e desactivante de agentes patogenicos das plantas
CA2265993A1 (en) Novel antimicrobial cosmetic compositions
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
AU692801B2 (en) Pharmaceutical compositions comprising a staurosporine as active ingredient.
DE60135927D1 (en) Nd
ATE279199T1 (de) Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten
EP1043015A3 (de) Homogene flüssige Duftstoff-Zusammensetzung auf Basis von flüchtigen Silikonen
US20110207832A1 (en) Skin disinfectant composition and methods for manufacturing and using
EA200200415A1 (ru) Композиция фармацевтического носителя
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
BR9802667C2 (pt) Composições farmacêuticas contendo ciclosporina como ingrediente ativo
RU2002116010A (ru) Антисептическое средство "АХДЕЗ 3000"
AR034494A1 (es) Composiciones para el tratamiento del cabello.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee